These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14703580)

  • 41. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit.
    Marshall C; Wolfe R; Kossmann T; Wesselingh S; Harrington G; Spelman D
    J Hosp Infect; 2004 Jul; 57(3):245-52. PubMed ID: 15236855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM).
    Spalding GJ; Hartrumpf M; Sierig T; Oesberg N; Kirschke CG; Albes JM
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1052-7. PubMed ID: 17398108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care.
    Tverdek FP; Crank CW; Segreti J
    Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The intensive care in the German Diagnosis Related Groups-System].
    Thix CA; Döbele AR; Unertl KE
    Bull Soc Sci Med Grand Duche Luxemb; 2008; (4):541-50. PubMed ID: 19024373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Future perspectives of cardiovascular intensive care medicine].
    Werdan K
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():80-3. PubMed ID: 16802527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The economic burden of sepsis in Austria.
    Schmid A; Schneider H
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1023-4; author reply 1024. PubMed ID: 12635473
    [No Abstract]   [Full Text] [Related]  

  • 48. Who should care for intensive care unit patients?
    Gutsche JT; Kohl BA
    Crit Care Med; 2007 Feb; 35(2 Suppl):S18-23. PubMed ID: 17242601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.
    Wernitz MH; Keck S; Swidsinski S; Schulz S; Veit SK
    Clin Microbiol Infect; 2005 Jun; 11(6):466-71. PubMed ID: 15882196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Which rate describes the MRSA situation appropriately?].
    Gastmeier P; Chaberny IF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1480-2. PubMed ID: 17583833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular biology on the ICU. From understanding to treating sepsis.
    Winning J; Claus RA; Huse K; Bauer M
    Minerva Anestesiol; 2006 May; 72(5):255-67. PubMed ID: 16675935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs of adverse events in intensive care units.
    Kaushal R; Bates DW; Franz C; Soukup JR; Rothschild JM
    Crit Care Med; 2007 Nov; 35(11):2479-83. PubMed ID: 17828035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Costs of critical care medicine.
    Pastores SM; Dakwar J; Halpern NA
    Crit Care Clin; 2012 Jan; 28(1):1-10, v. PubMed ID: 22123095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Using intensive medicine in progressive cases?].
    Gross H
    Dtsch Med Wochenschr; 2009 Sep; 134(38):p33. PubMed ID: 19760561
    [No Abstract]   [Full Text] [Related]  

  • 56. [The pharmacoeconomics of treatment of severe infections in intensive care].
    Zambrowski JJ
    Ann Fr Anesth Reanim; 2000 May; 19(5):430-5. PubMed ID: 10874445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nondrug costs of therapy in acute care--are they important?
    Edbrooke DL; Bourne RS
    Crit Care; 2003 Dec; 7(6):420-1. PubMed ID: 14624680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study questions increasing cost of intensive care of pneumocystis.
    AIDS Policy Law; 1995 Feb; 10(2):2. PubMed ID: 11362220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Intensive care medicine today].
    Van Aken H; Prien T; Berendes E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Apr; 38(4):264-72. PubMed ID: 12658568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of critical care.
    Barie PS; Ho VP
    Surg Clin North Am; 2012 Dec; 92(6):1445-62. PubMed ID: 23153878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.